ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Tobacco Control In The States Can Reduce Use, NCPB Says.

February 18, 2000

DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention

July 18, 1980

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Diet and Cancer Risk Explored In Studies Presented At AACR Annual Meeting

April 30, 2004

ASCO: NCI Authorities Still Important

June 11, 2010

GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies

July 18, 1980